AzTrials
AzTrials

Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn HealthNCT06379828

Self-assessment Tool for Implementing the ESCNH

An observational study of Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health and Testing of the Developed Self-assessment Tool in European Hospitals, run by Global Foundation for the Care of Newborn Infants at 1 site in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to develop a tool for hospitals to self-assess the implementation of the European Standards of Care for Newborn Health (ESCNH), standards defining best-practice procedures for neonatal care. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Please note that this is an observational study; not applicable
How many people
100 participants
Where
1 siteGermany
Study dates
3 Jun 2024to 1 Sep 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The PEG consists of 8 renowned experts of multidisciplinary professions: neonatologists, a (neonatal) nurses, an obstetrician, a parent representative, a public health expert, and a statistician and is completed by members of the EFCNI study team. The eDelphi panels will consist of experts from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy. Participants for the pilot-testing will be healthcare professionals with varying professional backgrounds in pilot hospitals across Europe.

Who may be able to join

None listed.

Who cannot join

  • provide insufficient proficiency of English for the eDelphi questionnaires or the languages of the self-assessment tool in the pilot testing, or
  • have a professional background that is not related to the ESCNH / individuals that are not parent representatives or representatives of caregiver of infants who received special/intensive care.
  • primarily work in the industry.

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • European Foundation for the Care of Newborn Infants (EFCNI)

    Munich, Bavaria, 81379

    Isabel Geiger, Dr., 0049 89 89 0 83 26-0, isabel.geiger@efcni.org

    Julia Hoffmann, Dr., julia.hoffmann@efcni.org

Other trials in Germany

About this study

Official title: Hospital Self-assessment Tool for the Implementation of the European Standards of Care for Newborn Health (ESCNH)

This study aims to develop a tool for hospitals to self-assess the implementation of the European Standards of Care for Newborn Health (ESCNH), standards defining best-practice procedures for neonatal care. The tool shall support healthcare professionals across Europe to measure the level of implementation of the ESCNH, to identify variations in care delivery, and ultimately to improve neonatal care. To achieve this, healthcare professionals from all relevant backgrounds and parent representatives will be invited to take part in an electronic Delphi consensus approach. A subsequent pilot-testing among at least 10 hospitals across Europe will refine the developed tool, indicate potential errors, ensure user-friendliness, and improve the applicability.

Read the detailed description

This project aims to develop a uniformly applicable self-assessment tool in different languages with the overall goal to support care providers across Europe to measure the level of implementation of the ESCNH, to pinpoint possible inhibitors, and ultimately to increase the extent of implementation. Covering the great variety of standards in one hands-on and easy-to-use self-assessment tool requires prioritising the most important components. This has to be approached in a systematic and scientific manner. For this purpose, a two-round electronic (e) Delphi survey will be conducted followed by an expert workshop. The aim of the two-stage eDelphi process is to lay a solid ground for the self-assessment tool. Prior to the eDelphi rounds, members of the study team together with the Project Expert Group (PEG) will condense and prioritise the ESCNH into one online questionnaire and thereby elaborate the first framework of the self-assessment tool. Next to participant-related information such as profession or country of employment, the questionnaire will cover specific aspects of the eleven major topics of the ESCNH namely: Birth and transfer, medical care and clinical practice, care procedures, infant- and family-centred developmental care, neonatal intensive care unit (NICU) design, nutrition, ethical decision-making and palliative care, follow-up and continuing care, patient safety and hygiene practice, data collection and documentation, education and training. The questionnaire will subsequently, in the first eDelphi round, be evaluated by the eDelphi panel. The panel consist of approximately 100 healthcare professionals from various disciplines related to neonatal care as well as parent representatives. In the first eDelphi round, panellists will appraise the relevance of included content, the wording of questions as well as the prioritisation of content to be included in the self-assessment tool. This will be enabled through a predefined evaluation scheme as well as free-text fields. Based on feedback from panellists, the preliminary self-assessment tool will be adapted by adding additional information, removing unnecessary items and re-wording if necessary. In the subsequent (second) eDelphi round, the same panellists will receive qualitative and quantitative information on the adaptation of the first version and will have again the option to evaluate the adapted questionnaire. Remaining discrepancies will be discussed in a final consensus workshop. For this purpose, 20-30 panellists will be selected based on their level of experience and invited for participation. The result of the workshop will be the agreed-upon content for the self-assessment tool. Except for the workshop, data collection during the eDelphi rounds will be anonymous.

To ensure applicability, the self-assessment tool will be pilot tested in European hospitals. For this purpose, the self-assessment tool will be translated into 5 languages (German, French, Italian, Swedish, Portuguese, and Spanish). For the pilot-testing, healthcare professionals in 10 pilot hospitals across Europe will be invited to evaluate the self-assessment tool. Feedback of the pilot-testing will be discussed with the PEG and adapted accordingly.

Being tested
Please note that this is an observational study; not applicable
Keywords
ESCNH, EFCNI, eDlephi method, Pilot-testing, Implementation, Self-assessment, Tool, Neonatal care standards

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Please note that this is an observational study; not applicableOther

    Please note that this is an observational study; not applicable

Study groups in NCT06379828
Study groupRoleWhat they receive
eDelphi panel/participantsThe eDelphi panels will consist of approximately 100 healthcare professionals from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy. 20-30 of them will be invited for a final consensus workshop.
Receives: Other: Please note that this is an observational study; not applicable
Pilot hospitals10 hospitals with neonatal units from Germany, UK, France, Italy, Sweden, Portugal, and Spain.
Receives: Other: Please note that this is an observational study; not applicable

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Online self-assessment tool (including statements and questions)

    Within a two-round eDelphi survey, the eDelphi panel will critically appraise the first template of the self-assessment tool. If required (indicated by ≥ 80% of participants) additional items will be added or unnecessary items will be removed. Remaining discrepancies will be discussed in a final consensus workshop and the questionnaire will be adapted based on consensus gathered within the workshop. The resulting questionnaire will be the first version of the self-assessment tool, which will be evaluated during and adapted after a pilot-testing phase.

    Measured: 15.06.2024 - 15.07.2025

Secondary outcomes (7)
  1. Response rates

    Number of participants completing the first and second eDelphi round, number of hospitals joining the pilot-testing phase

    Measured: 15.10.2024 - 30.06.2025

  2. Demographics and characteristics

    A summary of demographic information and the participants characteristics will be presented

    Measured: 15.10.2024 - 30.06.2025

  3. User-friendliness score of the self-assessment tool

    Time taken to fill in, illustration on screen, understandability

    Measured: 15.10.2024 - 30.06.2025

  4. Applicability score of the formulation of the questions

    Evaluation data on formulation of the questions and understandability

    Measured: 15.10.2024 - 30.06.2025

  5. Qualitative feedback on illustration of output

    Evaluation data on illustration of questionnaire on the screen

    Measured: 15.10.2024 - 30.06.2025

  6. Appraisal on the utilisation of the self-assessment tool

    Evaluation data on the utilisation of the self-assessment tool

    Measured: 15.10.2024 - 30.06.2025

  7. Scalability of the self-assessment tool and dissemination

    Evaluation data on the usage and outreach

    Measured: 15.10.2024 - 30.06.2025

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Apr 2024
  2. Study start3 Jun 2024 (estimated)
  3. Primary completion1 Oct 2025 (estimated)
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06379828
Sponsor's protocol ID
2024-0140
Status last verified
Apr 2024
First submitted
18 Apr 2024
Last updated
25 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lindacher V, Altebaeumer P, Marlow N, Matthaeus V, Straszewski IN, Thiele N, Pfeil JM, Zimmermann LJI, Mader S; European Standards of Care for Newborn Health project members. European Standards of Care for Newborn Health-A project protocol. Acta Paediatr. 2021 May;110(5):1433-1438. doi: 10.1111/apa.15712. Epub 2020 Dec 22.

    PubMed 33290600
  • Hoffmann J, Lehmann S, Ancora G, Hummler H, Lack N, Schlembach D, Schouten E, Simonelli I, Thernstrom Blomqvist Y, Vavouraki E, Webbe J, Zimmermann LJI, Mader S, Geiger I. Study protocol for the development and pilot-testing of a Self-assessment tool for the implementation of the European Standards of Care for Newborn Health (ESCNH). BMJ Paediatr Open. 2025 Jan 20;9(1):e003008. doi: 10.1136/bmjpo-2024-003008.

    PubMed 39837587

Questions about this trial

What is this clinical trial studying?

An observational study of Development of a Tool to Assess the Level of Implementing the European Standards of Care for Newborn Health and Testing of the Developed Self-assessment Tool in European Hospitals, run by Global Foundation for the Care of Newborn Infants at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Isabel Geiger, Dr. (+49 (0) 89 89 0 83 26-0, isabel.geiger@efcni.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Online self-assessment tool (including statements and questions) (time frame: 15.06.2024 - 15.07.2025). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06379828, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in